Lipoprotein-associated proteins involved in platelet signaling.
Platelets and lipoproteins are both key elements in the development of atherosclerosis and thrombosis. Based on their density, five classes of lipoproteins have been identified which all influence platelets via distinct mechanisms. The activation of platelets starts with binding of apolipoproteins to different platelet receptors and is followed by the activation of signaling pathways resulting in activation or inhibition of platelet functions like aggregation or secretion. In addition to apolipoproteins, lipoproteins are also associated to a large amount of proteins, enzymes and lipids that also can induce platelet activation or inhibition. This review provides a summary of the activation of signaling pathways after platelet-lipoprotein interactions initiated by lipoprotein-associated proteins and lipids.
Korporaal
Suzanne J A
SJ
Thrombosis and Haemostasis Laboratory, Department of Haematology, University Medical Center Utrecht and The Institute for Biomembranes, University of Utrecht, The Netherlands. j.a.korporaal@azu.nl
Akkerman
Jan-Willem N
JW
D000975:Antioxidants / Q000502:physiology; D001053:Apolipoproteins / Q000502:physiology; D001792:Blood Platelets / Q000502:physiology*; D006801:Humans; D008055:Lipids / Q000502:physiology; D008074:Lipoproteins / Q000145:classification / Q000378:metabolism* / Q000502:physiology; D015539:Platelet Activation; D015398:Signal Transduction
D000975:Antioxidants; D001053:Apolipoproteins; D008055:Lipids; D008074:Lipoproteins